IGC Pharma, Inc. — Director's Dealing 2015

May 13, 2015

SEC Form 4/A — Form 4/A

Issuer: India Globalization Capital, Inc. (IGC)
CIK: 0001326205
Period of Report: 2014-10-16

Reporting Person: PRINS RICHARD K (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-04-04	Common stock	G	1500	—	Disposed	51000	Direct
2014-04-11	Common stock	G	1500	—	Disposed	49500	Direct
2014-04-17	Common stock	G	1500	—	Disposed	48000	Direct
2014-04-25	Common stock	G	1500	—	Disposed	46500	Direct
2014-05-02	Common stock	G	1500	—	Disposed	45000	Direct
2014-05-09	Common stock	G	1500	—	Disposed	43500	Direct
2014-05-16	Common stock	G	1500	—	Disposed	42000	Direct
2014-05-23	Common stock	G	8000	—	Disposed	34000	Direct
2014-05-30	Common stock	G	1000	—	Disposed	33000	Direct
2014-06-06	Common stock	G	1000	—	Disposed	32000	Direct
2014-06-13	Common stock	G	1000	—	Disposed	31000	Direct
2014-06-20	Common stock	G	1000	—	Disposed	30000	Direct
2014-06-27	Common stock	G	1000	—	Disposed	29000	Direct
2014-07-03	Common stock	G	1000	—	Disposed	28000	Direct
2014-07-11	Common stock	G	1000	—	Disposed	27000	Direct
2014-07-18	Common stock	G	1000	—	Disposed	26000	Direct
2014-07-25	Common stock	G	1000	—	Disposed	25000	Direct
2014-08-01	Common stock	G	1000	—	Disposed	24000	Direct
2014-08-08	Common stock	G	1000	—	Disposed	23000	Direct
2014-08-15	Common stock	G	1000	—	Disposed	22000	Direct
2014-08-22	Common stock	G	1000	—	Disposed	21000	Direct
2014-08-29	Common stock	G	1000	—	Disposed	20000	Direct
2014-09-08	Common stock	G	1000	—	Disposed	19000	Direct
2014-09-12	Common stock	G	1000	—	Disposed	18000	Direct
2014-09-19	Common stock	G	1000	—	Disposed	17000	Direct
2014-09-26	Common stock	G	1000	—	Disposed	16000	Direct
2014-10-03	Common stock	G	1000	—	Disposed	15000	Direct
2014-10-16	Common stock	A	250000	—	Acquired	265000	Direct
2014-10-16	Common stock	A	50000	—	Acquired	315000	Direct
2014-10-27	Common stock	G	1000	—	Disposed	314000	Direct

Footnotes

F1: Represents shares of Restricted Stock awarded pursuant to a special grant approved by the Issuer's shareholders at the 2014 Annual Meeting of Stockholders. The shares vest upon certain performance metrics being achieved.

F2: Represents shares of Common Stock awarded pursuant to the Issuer's 2008 Omnibus Incentive Plan.